- Home
- CGNT vs ORGO Comparison
CGNT vs ORGO Comparison
Compare CGNT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGNT
- ORGO
- Stock Information
- Founded
- CGNT 2020
- ORGO 1985
- Country
- CGNT Israel
- ORGO United States
- Employees
- CGNT N/A
- ORGO N/A
- Industry
- CGNT Computer Software: Prepackaged Software
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- CGNT Technology
- ORGO Health Care
- Exchange
- CGNT Nasdaq
- ORGO Nasdaq
- Market Cap
- CGNT 680.1M
- ORGO 665.8M
- IPO Year
- CGNT N/A
- ORGO N/A
- Fundamental
- Price
- CGNT $9.30
- ORGO $4.45
- Analyst Decision
- CGNT Hold
- ORGO Buy
- Analyst Count
- CGNT 2
- ORGO 2
- Target Price
- CGNT $9.00
- ORGO $5.50
- AVG Volume (30 Days)
- CGNT 609.0K
- ORGO 1.4M
- Earning Date
- CGNT 06-17-2025
- ORGO 05-08-2025
- Dividend Yield
- CGNT N/A
- ORGO N/A
- EPS Growth
- CGNT N/A
- ORGO N/A
- EPS
- CGNT N/A
- ORGO N/A
- Revenue
- CGNT $350,632,000.00
- ORGO $482,043,000.00
- Revenue This Year
- CGNT $13.87
- ORGO $3.31
- Revenue Next Year
- CGNT $9.64
- ORGO $12.50
- P/E Ratio
- CGNT N/A
- ORGO N/A
- Revenue Growth
- CGNT 11.88
- ORGO 11.29
- 52 Week Low
- CGNT $6.21
- ORGO $2.17
- 52 Week High
- CGNT $11.12
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- CGNT 53.57
- ORGO 52.57
- Support Level
- CGNT $9.10
- ORGO $4.11
- Resistance Level
- CGNT $9.91
- ORGO $4.38
- Average True Range (ATR)
- CGNT 0.53
- ORGO 0.35
- MACD
- CGNT 0.02
- ORGO 0.03
- Stochastic Oscillator
- CGNT 45.95
- ORGO 80.17
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.